China and U.S. Deepen Anti-Drug Collaboration in 11th Intelligence Exchange
China and the U.S. reinforce anti-drug partnership through intelligence sharing and joint investigation plans during their 11th annual exchange meeting.
News & Insights Across Asia
China and the U.S. reinforce anti-drug partnership through intelligence sharing and joint investigation plans during their 11th annual exchange meeting.
China’s Ministry of Public Security strongly opposes the U.S. decision to impose additional tariffs on Chinese imports over fentanyl issues, urging cooperation instead of blame.
China and the U.S. are collaborating to combat the opioid crisis, focusing on fentanyl control. Despite progress, challenges persist as both nations work to overcome barriers in addressing this epidemic.
China urges the United States to value joint efforts in drug control cooperation, emphasizing the importance of continued collaboration amid rising trade tensions.
China and the United States have agreed to deepen pragmatic cooperation on drug control, following the tenth China-U.S. Narcotics Control Strategic Intelligence Sharing Conference in Shanghai.
China and the United States have agreed to maintain communication on drug control and enhance law enforcement cooperation following a pivotal meeting between senior officials from both nations.
China disputes the United States’ recent designation of it as a major drug-producing country, highlighting its strict drug control measures and urging for collaborative solutions to the global drug crisis.